MedTrace Logo

Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

NCT00257959 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2006-07-27

No results posted yet for this study

Summary

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

Conditions

  • Ventricular Tachycardia

Interventions

DRUG

amiodarone beta blocker sotalol

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Connolly, Stuart, M.D.

    lead INDIV

Principal Investigators

  • Stuart Connolly · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2004-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257959 on ClinicalTrials.gov